Kedu ihe "Clear" pụtara?
Anumanu anaghị ebu mmụpụta. Ọ gaghị ebute ọrịa ahụ na agaghị enyefe ya.
Alpha Mannosidosis (AlphaMan) is a rare genetic disorder affecting cats, caused by a deficiency of the enzyme alpha-mannosidase. This DNA test helps identify carriers and affected cats, enabling responsible breeding decisions to prevent the spread of the disease. Early detection through the Alpha Mannosidosis DNA test is crucial for managing symptoms and improving feline health. By screening your cat, you contribute to reducing the incidence of AlphaMan in future generations. Trusted by veterinarians and breeders, this test provides accurate and reliable results. Ensure your cat’s well-being with the Alpha Mannosidosis DNA test today. Protect your feline companion from hereditary health risks with this essential genetic screening.
Alpha Mannosidosis (AlphaMan) is a rare genetic disorder in cats caused by a deficiency of the enzyme alpha-mannosidase. This leads to the accumulation of complex sugars in cells, resulting in progressive neurological and physical symptoms. A DNA test for AlphaMan helps identify carriers and affected cats, enabling responsible breeding decisions. Early detection through testing can improve management and care for affected cats. Genetic screening is essential to reduce the incidence of this debilitating condition in feline populations.
Agụnyere ule DNA a site na mkpọ anyị Basic - ma bụrụkwa akụkụ nke ngwugwu Basic, Standard, Advanced, Complete.
Lelee ngwugwu ule DNA →Alpha Mannosidosis (AlphaMan) is a rare genetic disorder that affects the metabolism of certain sugars in the body. It is caused by a deficiency in the enzyme alpha-mannosidase, which is responsible for breaking down mannose-containing oligosaccharides. When this enzyme is deficient or absent, these sugars accumulate in the body's cells, leading to a range of health issues.
Cats with Alpha Mannosidosis may exhibit a variety of clinical symptoms that can vary in severity. Common signs include neurological deficits, such as poor coordination, muscle weakness, and behavioral changes. Additionally, affected cats might experience growth delays, skeletal abnormalities, and impaired immune function. The onset of symptoms can occur at different ages, often leading to a progressive decline in health over time.
Diagnosing Alpha Mannosidosis typically involves a combination of clinical evaluation and laboratory testing. A veterinarian will assess the cat's medical history and symptoms, followed by conducting biochemical tests to measure enzyme activity. Genetic testing through DNA analysis can confirm the presence of mutations in the gene responsible for encoding the alpha-mannosidase enzyme, providing a definitive diagnosis.
Currently, there is no cure for Alpha Mannosidosis, and treatment is primarily supportive. Management strategies may include symptomatic care to improve the quality of life for affected cats. This can involve nutritional support, physical therapy, and regular veterinary check-ups to monitor the animal's condition. Research is ongoing to explore potential therapeutic options, including enzyme replacement therapy and gene therapy, which may offer hope for future treatments.
Genetic testing for Alpha Mannosidosis is crucial for breeders and pet owners to identify carriers of the gene mutation and prevent the propagation of this disorder. By understanding the genetic status of their cats, responsible breeding practices can be implemented to reduce the risk of this condition in future generations. Additionally, early detection through DNA testing can help owners make informed decisions regarding the health management of their pets.
Anumanu anaghị ebu mmụpụta. Ọ gaghị ebute ọrịa ahụ na agaghị enyefe ya.
Mba. Anụmanụ ahụ nwere ahụike mana ọ nwere ike ibunye ngbanwe na ya ụmụ.
Ọ na-ebu mkpụrụ akwụkwọ mutated abụọ. A na-atụ anya akara ahụike dabere na ọrịa ahụ. E kwesịghị ịzụ ya.
Ụfọdụ ọrịa ndị metụtara mmekọahụ, ya mere okwu ha dịgasị iche dabere na mmekọahụ anụmanụ.
This DNA test detects the mutation associated with Alpha Mannosidosis (AlphaMan) in order to identify clear, carrier, or at-risk animals.
Nnwale DNA na-enyere ndị na-azụ anụ aka ịhazi mating dị mma ma belata ohere nke ibunye ngbanwe ahụ nye ụmụ.
Ụdị ihe nketa a kọrọ maka ule a bụ Autosomal Recessive.
This test analyses the mutation MAN2B1 c.1749_1752del.
Ọ bụchaghị. Ntụgharị asụsụ dabere na ụkpụrụ nketa na genotype nke ga-esi na ya pụta.
Berg T, Tollersrud O K, Walkley S U, Siegel D, Nilssen O. Purification of feline lysosomal alpha-mannosidase, determination of its cDNA sequence and identification of a mutation causing alpha-mannosidosis in Persian cats. Biochem J. 1997 Dec 15;328 ( Pt 3)(Pt 3):863-70. doi: 10.1042/bj3280863.
Nzuzo gị, nhọrọ gị
Anyị na-eji kuki dị mkpa iji mee webụsaịtị. Kuki nhọrọ (dị ka ndị na-eweta ọdịnaya agbakwunyere) na ndabara nwere nkwarụ ma na-enyere ya aka ma ọ bụrụ na ị kwenyere. Ị nwere ike ịgbanwe nhọrọ gị oge ọ bụla site na iji bọtịnụ "Kuki".
Achọrọ maka njirimara isi yana nchekwa. Agbanyere mgbe niile.
Na-emeziwanye atụmatụ dị ka ichekwa mmasị ma ọ bụ ntinye anaghị agbasa ozi.
Na-enyere anyị aka ịghọta ojiji saịtị. Agbanyụrụ na ndabara.
Mgbasa ozi / nsuso n'ofe saịtị (ụfọdụ vidiyo/maps agbakwunyere). Agbanyụrụ na ndabara.